View in EDS

484: SAKK 16/18: QA and interim safety of immune-modulatory RT in resectable stage III(N2) NSCLC.

Saved in:

Bibliographic Details
Title:	484: SAKK 16/18: QA and interim safety of immune-modulatory RT in resectable stage III(N2) NSCLC.
Authors:	Finazzi, Tobias (AUTHOR), Holer, Lisa (AUTHOR), Tang, Hongjian (AUTHOR), Riesterer, Oliver (AUTHOR), Allal, Abdelkarim (AUTHOR), Elicin, Olgun (AUTHOR), Glatzer, Markus (AUTHOR), Durham, André (AUTHOR), Martucci, Francesco (AUTHOR), Adam, Lukas (AUTHOR), Mosna-Firlejczyk, Katarzyna (AUTHOR), Bettini, Adrienne (AUTHOR), König, David (AUTHOR), Haefliger, Simon (AUTHOR), Früh, Martin (AUTHOR), Janthur, Wolf-Dieter (AUTHOR), Addeo, Alfredo (AUTHOR), Froesch, Patrizia (AUTHOR), Mark, Michael (AUTHOR), Scheibe, Bernhard (AUTHOR)
Source:	Radiotherapy & Oncology. 2024 Supplement 1, Vol. 194, pS1610-S1612. 3p.
Database:	Academic Search Ultimate

Description
ISSN:	01678140
DOI:	10.1016/S0167-8140(24)01092-2